We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKSI icon
1101
MKS Inc
MKSI
$17.9B
$291K ﹤0.01%
+2,681
New +$319K
IEV icon
1102
iShares Europe ETF
IEV
$1.63B
$291K ﹤0.01%
5,000
R icon
1103
Ryder
R
$9.82B
$291K ﹤0.01%
1,998
+3
+0.2% +$407
IHG icon
1104
InterContinental Hotels
IHG
$23.8B
$291K ﹤0.01%
2,635
-310
-11% -$31.7K
VOX icon
1105
Vanguard Communication Services ETF
VOX
$5.68B
$291K ﹤0.01%
2,002
-270
-12% -$37.3K
MDU icon
1106
MDU Resources
MDU
$4.26B
$291K ﹤0.01%
+19,165
New +$273K
PBA icon
1107
Pembina Pipeline
PBA
$29.3B
$291K ﹤0.01%
7,051
+5,051
+253% +$197K
POWI icon
1108
Power Integrations
POWI
$3.16B
$288K ﹤0.01%
4,495
+498
+12% +$32.9K
BRC icon
1109
Brady Corp
BRC
$4.52B
$288K ﹤0.01%
3,755
+198
+6% +$14.1K
RNST icon
1110
Renasant Corp
RNST
$4.02B
$288K ﹤0.01%
+8,847
New +$294K
CABO icon
1111
Cable One
CABO
$242M
$287K ﹤0.01%
820
-1
-0.1% -$358
KBWB icon
1112
Invesco KBW Bank ETF
KBWB
$6.82B
$287K ﹤0.01%
4,890
AWR icon
1113
American States Water
AWR
$3.48B
$286K ﹤0.01%
3,428
+288
+9% +$23.2K
SAIA icon
1114
Saia
SAIA
$10.5B
$285K ﹤0.01%
652
+209
+47% +$88.5K
FOXF icon
1115
Fox Factory Holding Corp
FOXF
$788M
$284K ﹤0.01%
6,851
-247
-3% -$10.7K
FUN icon
1116
Cedar Fair
FUN
$1.9B
$284K ﹤0.01%
7,033
-10,602
-60% -$485K
ESS icon
1117
Essex Property Trust
ESS
$19B
$283K ﹤0.01%
959
+15
+2% +$4.35K
DORM icon
1118
Dorman Products
DORM
$4.26B
$283K ﹤0.01%
2,503
+15
+0.6% +$1.58K
DAR icon
1119
Darling Ingredients
DAR
$9.28B
$283K ﹤0.01%
7,609
+412
+6% +$15.5K
MGM icon
1120
MGM Resorts International
MGM
$11.7B
$281K ﹤0.01%
7,201
+1,948
+37% +$77.1K
ENVX icon
1121
Enovix
ENVX
$836M
$281K ﹤0.01%
34,354
-95
-0.3% -$987
SCHF icon
1122
Schwab International Equity ETF
SCHF
$64.9B
$281K ﹤0.01%
13,646
E icon
1123
ENI
E
$78.1B
$280K ﹤0.01%
9,252
-462
-5% -$14.5K
STLD icon
1124
Steel Dynamics
STLD
$36.8B
$280K ﹤0.01%
2,222
-62,381
-97% -$7.58M
SLF icon
1125
Sun Life Financial
SLF
$45.8B
$279K ﹤0.01%
4,813
-4,692
-49% -$245K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.